| DIRECT COMPETITOR COMPARISON | |
| FLML | APPA | EMIS.OB | JNJ | Industry | | Market Cap: | N/A | N/A | N/A | N/A | N/A | | Employees: | 284 | 32 | 20 | 118,700 | N/A | | Qtrly Rev Growth (yoy): | 8.40% | 1,645.30% | N/A | -5.30% | N/A | | Revenue (ttm): | 40.99M | 1.16M | 5.00K | 60.53B | N/A | | Gross Margin (ttm): | 78.37% | 100.00% | 100.00% | 71.08% | N/A | | EBITDA (ttm): | -8.40M | -11.60M | -15.43M | 19.05B | N/A | | Oper Margins (ttm): | -37.95% | -1,032.16% | -322,640.00% | 26.94% | N/A | | Net Income (ttm): | -8.47M | -11.98M | -21.34M | 12.77B | N/A | | EPS (ttm): | -0.350 | -0.389 | -0.673 | 4.579 | N/A | | P/E (ttm): | N/A | N/A | N/A | 14.09 | N/A | | PEG (5 yr expected): | N/A | N/A | N/A | 1.89 | N/A | | P/S (ttm): | N/A | N/A | N/A | N/A | N/A |
|
| APPA = AP Pharma Inc. | | EMIS.OB = Emisphere Technologies, Inc. | | JNJ = Johnson & Johnson | |
| NEWS ON DIRECT COMPETITORS | |
| • | JNJ | | Sweet 16 Dividend Picks For Next Year: Chief Investor
Tue 4:49pm -
at CNBC | | • | JNJ | | The Best Stocks for 2009, Revisited
Tue 3:54pm -
at Motley Fool | | • | JNJ | | New Contract for Integra
Tue 3:38pm -
Zacks.com | | • | JNJ | | This Acquisition Is Icy Hot
Tue 3:10pm -
at Motley Fool | | • | JNJ | | Which stakeholder should get priority?
Tue 2:40pm -
at FT.com | | • | JNJ | | R&D Spending: Numbers for Pfizer, J&J, Merck, Lilly and Bristol
Tue 2:02pm -
at The Wall Street Journal Online | | • | JNJ | | 5 All-Star Dividend Stocks
Tue 2:01pm -
at Motley Fool | | • | EMIS.OB | | Meta-Analysis of Independent Research Supports Potential for Oral Salmon Calcitonin Using Emisphere's Eligen® Technology as Therapeutic Option for Persistent Musculoskeletal Pain
Mon 9:00am -
Business Wire | | • | EMIS.OB | | Emisphere Technologies Reports DMC Recommendation to Proceed with Phase 3 Clinical Trials with Oral Calcitonin for Osteoporosis and Osteoarthritis
Thu, Dec 10 -
Business Wire | | • | EMIS.OB | | EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Mon, Nov 30 -
EDGAR Online | | • | EMIS.OB | | Emisphere Technologies Announces Extension of Maturity Date for Novartis Convertible Promissory Note
Mon, Nov 30 -
Business Wire | | • | APPA | | AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
Tue, Nov 24 -
EDGAR Online | | • | EMIS.OB | | Emisphere Technologies to Present at the New York Society of Security Analysts' 13th Annual Biotech & Specialty Pharma Investment Conference
Tue, Nov 24 -
Business Wire | | • | APPA | | A.P. Pharma Receives Notice of Compliance with Nasdaq Continued Listing Requirements
Mon, Nov 23 -
Business Wire | | • | APPA | | AP PHARMA INC /DE/ Financials
Fri, Nov 20 -
EDGAR Online Financials | | • | APPA | | AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
Mon, Nov 16 -
EDGAR Online | | • | APPA | | AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report
Mon, Nov 16 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|
0.49% Nasdaq 
Competitors
